MedTrace Logo

REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)

NCT06373692 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1508

Last updated 2024-04-18

No results posted yet for this study

Summary

The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma.

Conditions

  • Bronchial Asthma

Sponsors & Collaborators

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

    collaborator OTHER

  • Tianjin University of Traditional Chinese Medicine

    collaborator OTHER

  • Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

    collaborator OTHER

  • Hebei Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER_GOV

  • Peking University People's Hospital

    collaborator OTHER

  • The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

    collaborator OTHER

  • The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

    collaborator OTHER

  • Henan University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Jian-sheng Li, Professor · The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-12-30
Completion
2026-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06373692 on ClinicalTrials.gov